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Abstract
Background: Fundal pressure (pushing on the upper part of the uterus in the direction of the birth canal) is often
performed in routine practice, however the benefit and indications for its use are unclear and vigorous pressure is
potentially harmful. There is some evidence that it may be applied routinely or to expedite delivery in some situations
(e.g. fetal distress or maternal exhaustion), particularly in settings where other methods of achieving delivery (forceps,
vacuum) are not available. Gentle assisted pushing (GAP) is an innovative method of applying gentle but steady
pressure to the uterine fundus with the woman in an upright posture. This trial aims to evaluate the use of GAP in an
upright posture, or upright posture alone, on reducing the mean time of delivery and the associated maternal and
neonatal complications in women not having delivered following 15-30 min in the second stage of labour.
Methods/Design: We will conduct a multicentre, randomized, unblinded, controlled trial with three parallel arms
(1:1:1). 1,145 women will be randomized at three hospitals in South Africa. Women will be eligible for inclusion if they
are ≥18 years old, nulliparous, gestational age ≥ 35 weeks, have a singleton pregnancy in cephalic presentation and
vaginal delivery anticipated. Women with chronic medical conditions or obstetric complications are not eligible. If
eligible women are undelivered following 15-30 min in the second stage of labour, they will be randomly assigned to:
1) GAP in the upright posture, 2) upright posture only and 3) routine practice (recumbent/supine posture). The primary
outcome is the mean time from randomization to complete delivery. Secondary outcomes include operative delivery,
adverse neonatal outcomes, maternal adverse events and discomfort.
Discussion: This trial will establish whether upright posture and/or a controlled method of applying fundal pressure
(GAP) can improve labour outcomes for women and their babies. If fundal pressure is found to have a measurable
beneficial effect, this gentle approach can be promoted as a replacement for the uncontrolled methods currently in
use. If it is not found to be useful, fundal pressure can be discouraged.
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Background
The first stage of labour is the period of time from the
onset of intense, synchronous and co-ordinated contrac-
tions leading to full cervical dilatation. The second stage
of labour is the period from full cervical dilatation to ex-
pulsion of the baby through the vagina. UK guidelines
define the normal duration of the second stage of labour
to be about 0.5 to 2.5 h for nulliparous women, and up
to 2 h in parous women following the onset of the active
second stage of labour [1]. There is little consensus as to
what constitutes a prolonged second stage of labour. UK
guidelines define it as more than two hours and one
hour of the onset of the active second stage for nullipar-
ous and parous women, respectively [1]. After this time,
women in the UK are referred for operative vaginal
birth. Poor contractions, maternal exhaustion, epidural
analgesia and occipito-posterior fetal positions are com-
mon causes of prolonged second stage. These causes can
be difficult to overcome without interventions such as
oxytocin (to stimulate or augment uterine contractions)
and assisted vaginal birth (such as forceps or vacuum).
Fundal pressure involves the application of pressure by
the birth attendant to the uppermost part of a woman’s
uterus, directed towards the birth canal, in an attempt to
assist spontaneous vaginal delivery [2]. Applying manual
fundal pressure was originally described by Samuel
Kristeller in the 1870s and was known as the Kristeller
manoeuvre. Nowadays, although this manoeuvre is not
officially taught to midwives and doctors, the use of
manual fundal pressure is still performed in clinical
practice, although often not documented in clinical re-
cords [3]. Applying fundal pressure under controlled
conditions has been shown to increase intrauterine pres-
sure [4]. This increase in the expulsive uterine forces
could potentially assist the mother to push the baby out.
There is evidence to show that fundal pressure is used in
formal and informal childbirth practice, in developed
and less developed countries [5–8]. However, how fre-
quently fundal pressure is performed in routine practice
and the indications for its’ use in different settings is un-
clear. In a 2006 postpartum survey of women in the
USA, it was reported that there was a ‘notable minority’
of births during which ‘a staff member pressed on the
mother's belly to help push the baby out’ [7]. A survey
in the Netherlands between 1994 and 1995 reported a
prevalence of 4 % [8]. Two other studies in tertiary care
institutions have reported the incidence of fundal pres-
sure application to be 23-24 % [9, 10]. It may be applied
routinely, in prolonged second stage of labour, for situa-
tions where delivery needs to be expedited (e.g. fetal dis-
tress) or for maternal medical conditions where
prolonged pushing is contraindicated [2]. Fundal pres-
sure is also used routinely to assist birth at Caesarean
section.
The safety of this intervention has not been estab-
lished [3, 11–13], and its use remains controversial [13].
Applying fundal pressure has been both recommended
and condemned as a strategy for assisting birth in the
management of shoulder dystocia [14, 15]. To our know-
ledge, the only published randomized controlled trials
(RCTs) of manual fundal pressure during vaginal birth
have found no benefits associated with its use, but the
numbers studied were small [16, 30]. A pilot RCT of
manual fundal pressure compared with standard care in
209 nulliparous women with uncomplicated pregnancies
in a hospital in India found no significant reduction in
the duration of the second stage of labour, but an in-
crease in perineal injuries [16]. A 2005 review of the
manoeuvre concluded that the role of fundal pressure is
understudied and caution should be exercised until it is
proven to be safe and effective [11]. A 2009 Cochrane
review concluded that there is currently insufficient high
quality evidence to draw firm conclusions about the ben-
efits and risks of this practice [2].
Fundal pressure is usually applied manually; however,
two small RCTs (conducted in hospitals in South Korea
and Italy) have evaluated fundal pressure applied using
two different types of inflatable belts compared with
standard care in nulliparous women with uncomplicated
singleton pregnancies [17, 18]. These studies reported a
significant reduction in the duration of the second stage
of labour and, in the study in Italy, a significant reduc-
tion in perineal trauma, CS, vacuum delivery and neo-
natal ICU admission.
Potential benefits and risks of fundal pressure
In well-resourced settings, a prolonged second stage of
labour is usually overcome by assisted vaginal delivery
or caesarean section. In lower-income countries, for the
majority of births, instrumental or operative delivery
methods may not be available; and timely transfer to a
service with these facilities may not be feasible. In these
settings, fundal pressure may be an effective way of ex-
pediting the birth of a baby, and potentially reducing the
risk of neonatal morbidity and mortality associated with
a prolonged and difficult birth. In addition, this interven-
tion may be valuable for women in whom instrumental
delivery is contraindicated (such as HIV infection) and
for whom assistance in the second stage of labour is ne-
cessary. However, even in settings where instrumental or
operative delivery is available, fundal pressure may re-
duce the need for their use and, thereby, reduce the risk
of associated third-degree tears or surgery. The potential
benefits, therefore, have implications for obstetric care at
all levels.
Fundal pressure manoeuvres of variable force and direc-
tion are commonly used by birth attendants with poten-
tially harmful effects. Maternal complications ascribed to
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these ‘conventional’ fundal pressure manoeuvres include
perineal tears, uterine rupture, uterine inversion, pain,
hypotension, respiratory distress, abdominal bruising,
fractured ribs, and liver rupture [19–26]. Excessive fundal
pressure has also been cited as a predisposing factor for
amniotic fluid embolism [27]. In the neonate, fundal pres-
sure has been implicated as a possible cause of fractures
and brain damage [28, 29]. The theoretical basis for the
latter is that applying mechanical forces to the uterus to
increase intrauterine pressure could cause a concomitant
increase in fetal intracranial pressure. This, in turn, could
lead to a decrease in fetal cerebral blood flow and subse-
quent cerebral handicap in the infant. The same mechan-
ism has been postulated to occur in cases of cerebral palsy
following uterine tetany or forceps delivery. In addition, if
used in the presence of cephalo-pelvic disproportion, the
risk of maternal and neonatal injury would be high.
There is also a theoretical possibility that fundal pres-
sure may cause maternal-fetal transfusion of blood, in-
creasing the risk of viral transmission such as HIV.
However, in a randomized trial of fundal pressure versus
no fundal pressure at caesarean section, no evidence of
maternal-fetal transfusion was found [30].
The lack of a standardised method of application is
also contributing to differences of opinion regarding the
utility of fundal pressure. Although it has been described
as being ‘applied gently with one hand on the uterine
fundus at a 30° to 45° angle to the maternal spine in the
direction of the pelvis’ [13], in a longitudinal direction, it
is difficult to quantify or control the amount of force
used. Fundal pressure may vary from the gentle pressure
described above, to vigorous force applied with both
hands or elbows using the attendant’s whole weight. A
tendency to use rapid thrusting movements may cause
sharp rises in intrauterine pressure and increase the risk
of maternal and neonatal injury. The gentle assisted
pushing (GAP) method described in this protocol is de-
signed to eliminate the possibility of excessive use of
force, by positioning the attendant behind the women
who is in an upright position, so that only the pressure
applied with her hands can be used.
The role of maternal posture
In the 1800s, it was noted that women would give birth
in upright positions using posts, hammocks or furniture,
or that women might kneel, crouch, or squat using
bricks, stones, or a birthing stool [31]. Upright positions
adopted during the first stage of labour have been shown
in a systematic review to reduce the duration of labour
by about one hour [32]. Upright postures may enhance
progress in the second stage of labour and reduce opera-
tive delivery, however the limited evidence available is
inconclusive. A systematic review of maternal position
in the second stage of labour revealed several benefits
due to upright posture (e.g. fewer instrumental deliver-
ies, fewer abnormal fetal heart rate patterns, a trend to
shorter second stage) however, it also revealed a possible
association with more blood loss [33]. In this review, it
was suggested that blood loss may have been more ac-
curately estimated in the women allocated to upright
birth in a specially designed birth chair in which blood
loss was collected in a receptacle. Assuming an upright
kneeling or squatting position for the second stage of
labour may facilitate vaginal delivery, by enabling the
mother to bear down more efficiently with the alignment
of physiological and gravitational forces, as well as tilting
the pelvis to a more favourable (less oblique) orientation
to the direction of the uterine and bearing down forces.
However, in practice the second stage of labour is often
performed in recumbent or semi-recumbent positions,
which some claim enables birth attendants to better
monitor and gain access to the baby [31].
Pilot study
We conducted a pilot study in the form of a RCT, to de-
termine the feasibility of a larger RCT to evaluate this
new method of gentle fundal pressure called “gentle
assisted pushing” (GAP), which was performed with the
woman in an upright posture. The pilot study protocol
was approved by the Ethics Committee, East London
Hospital Complex, and the Committee for Research on
Human Subjects, University of the Witwatersrand.
This two-armed RCT recruited 120 healthy, nullipar-
ous women with a singleton pregnancy in cephalic pres-
entation at ≥35 weeks who consented to participate.
Women undelivered by 15 min of bearing down (second
stage) were randomized (1:1) to 1) gentle assisted push-
ing in an upright posture, or 2) upright posture only.
The attendants were two research midwives who were
taught the fundal pressure technique by the lead investi-
gator. During contractions, steady firm fundal pressure
was applied using the palms of both hands in the direc-
tion of the pelvis using only the strength of her fore-
arms. Steady, sustained pressure was maintained for the
full duration of each contraction or 30 s, whichever was
shorter. Forceful or rapid pressure and the use of body
weight to apply pressure were avoided. The results of
this unpublished pilot study showed a non-significant
trend towards reduce rate of operative delivery. From
this pilot, it was concluded that the GAP method was
clinically feasible and that the results justified a larger
trial to study the effectiveness and safety of this inter-
vention, and its relationship to posture, in the second
stage of labour.
This larger trial will add to the body of knowledge on
upright posture versus recumbent posture. By addition-
ally using gentle assisted pressure combined with the
upright posture, the expulsive forces acting on the
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uterus should be optimised. To differentiate possible ef-
fects of gentle assisted pushing and posture, and to sup-
plement the evidence base on the effectiveness of
upright posture, a three-armed comparison will be used.
Study objectives
This three-arm trial aims to evaluate the use of gentle
assisted pushing in an upright posture (GAP). We will
determine whether:
1. GAP is associated with reduced duration of second
stage of labour, and improved neonatal and maternal
outcomes, compared with current routine practice
(typically recumbent/supine posture).
2. Upright posture alone is associated with a reduced
duration of second stage of labour, and improved
neonatal and maternal outcomes, compared with
current routine practice (typically recumbent/supine
posture).
3. GAP (gentle fundal pressure in an upright posture)
is associated with reduced duration of second stage
of labour, and improved neonatal and maternal
outcomes, compared with upright posture alone.
Methods
Study design
The GAP study is a multicentre, randomized, controlled,
unblinded, clinical trial with three parallel arms (1:1:1).
Please see Fig. 1 for a graphical outline of the study.
Study setting
The study will be conducted in four sites at three mater-
nity facilities in South Africa, namely:
 Frere Hospital, East London – a tertiary-level hos-
pital with approximately 800 beds in total, with an
estimated 570 deliveries per month. There are two
study sites at Frere Hospital:
o Dancan Village Day Hospital - Midwife-led ob-
stetric unit
o Frere labour ward - Obstetrician-led obstetric
unit
 Cecilia Makiwane Hospital, East London – a
secondary-level hospital with approximately 700
beds in total, with an estimated 400 deliveries per
month
 Butterworth Hospital – a district hospital with
approximately 400 beds in total, with an estimated
400 deliveries per month
Study participants
All women attending participating hospitals for delivery
(who meet the inclusion criteria) during the study period
will be approached for participation in this study.
The eligibility criteria are:
 Equal to or greater than 18 years old;
 Nulliparous women;
 Gestational age ≥ 35 weeks;
 Singleton pregnancy;
Fig. 1 Flow chart for the GAP study
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 Vaginal delivery anticipated;
 Cephalic fetal presentation;
 Baby’s heartbeat detected;
 No chronic medical conditions, including heart
disease, epilepsy, hypertension, diabetes mellitus and
renal disease;
 No obstetric complications, including hypertensive
disorders of pregnancy, cephalo-pelvic dispropor-
tion, antepartum haemorrhage, intra-uterine growth
restriction, fetal distress, intra-amniotic infection;
and
 Willing and able to provide consent
Women whose labours are induced or augmented, or
women with HIV, are not excluded from this trial. How-
ever, this information will be captured in the trial forms.
Recruitment and screening procedures
In participating facilities, nulliparous women ≥18 years
old will be approached with information about the trial.
Women who are in latent phase of labour and who meet
the eligibility criteria will be fully counselled and in-
formed about the trial. The following guidelines will be
used for screening:
 The woman should be sufficiently comfortable to
make an informed choice.
 Information should be provided in her home
language.
 She will be given an information sheet and offered
time to reflect and ask questions, or to consult with
family members.
 If she agrees, she will sign the informed consent
form
 Illiterate participants will have the consent form
read to them.
 Verbal consent will be witnessed by an independent
signatory.
 Following receipt of the signed consent form,
baseline demographic and clinical data will be
recorded on the screening form.
 Screened women will be given a screening number,
including women who decline to take part and those
who are not eligible. All screening forms will be kept
by the study team.
Sampling and allocation
Recruited women who reach second stage of labour
without major complications will be randomized. The
randomization sequence will be generated by the WHO/
RHR Statistics and Informatics (SIS) team. This will be
computer-generated in balanced blocks of variable size,
in a ratio of 1:1:1 for the three study arms. Details of the
group allocation will be concealed on cards inside a
sequentially-numbered series of sealed, opaque enve-
lopes. These will be prepared by the SIS team, separately
for each study site. Allocation will be performed by the
research assistant, by opening the next numbered enve-
lope in the series. The assignment schedule will be
stored at WHO, and will not be accessible to the on-site
research teams.
Study interventions
Participants will be allocated to one of the following
intervention groups:
 Arm 1: GAP (gentle fundal pressure in an upright
posture)
 Arm 2: Upright posture only
 Arm 3: Routine practice (typically recumbent/supine
posture)
Labour ward staff at the study sites will be trained in
these study procedures before the start of recruitment.
Arm 1: GAP (gentle fundal pressure in an upright posture)
The principle of the procedure is for the birth attendant
(a midwife or doctor) to apply steady (firm yet gentle)
manual pressure on the uterine fundus in the direction
of the pelvis, for the full duration of each uterine con-
traction, but not exceeding 30 s. Forceful or rapid pres-
sure is to be avoided.
Gentle assisted pressure will be applied by attendants
who have been trained in the procedure, via a video
teaching aid and practical demonstration by the study
team. These training materials and methods will be stan-
dardized to ensure comparability of training and GAP
administration across study sites. The woman will be
assisted to assume an upright kneeling or squatting pos-
ture on the bed. The trained birth attendant will kneel
behind her on the bed or stand behind her with the
woman positioned at right angles to the length of the
bed and back close to the side of the bed. The trained
birth attendant will wrap her arms around the woman
passing below her axillae, and place both open palms,
overlapping, on the fundus of her uterus. Steady pres-
sure in the long axis of the uterus will be applied only
during contractions. The duration of pressure will be
limited to 30 s, with a minimum of 30 s rest before the
next pressure.
The position of the trained birth attendant in relation to
the mother ensures that excessive force using the assis-
tant’s weight cannot be used, as occurs with conventional
fundal pressure when the woman is supine and the trained
birth attendant is standing alongside her. The upright pos-
ture is integral to this intervention. During training, a
manikin will be used with a small air-filled bladder be-
tween the trained birth attendant’s hands and the manikin
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abdomen, connected to a beaumanometer so that the
amount of pressure can be monitored.
Arm 2: Upright posture
Participating women will be encouraged to assume an
upright crouching or kneeling position during the sec-
ond stage of labour. When the baby’s head is ‘crowning’,
the trained birth attendant may choose to move the
woman to a recumbent position for the birth.
Arm 3: Routine practice (recumbent/supine posture only)
The current posture as practiced in the participating
sites will be used.
In all intervention arms, the trained birth attendant
encourages the women to bear down. All other delivery
procedures, such as fetal heart monitoring and routine
oxytocin after the birth, are performed according to the
usual hospital routine and will not differ between the
groups.
For Arm 3 (routine practice), if the woman remains
undelivered 30 min after randomization, fundal pressure
or changes in posture may be considered necessary by
the birth attendant according to routine local practice.
Additional procedures or treatments performed at the
discretion of the attendant will then be recorded in the
study form.
At any stage of the labour, routine procedures such as
change in posture, oxytocin administration, forceps or
vacuum delivery or caesarean section will be available as
considered indicated by the responsible clinician. If for-
ceps, vacuum delivery or caesarean section is required,
GAP and/or upright only posture will be stopped.
Electronic fetal heart rate monitoring is not routinely
used in the study institutions in uncomplicated preg-
nancies; therefore, this equipment is unlikely to inter-
fere with the administration of the interventions in this
study. Auscultation of the fetal heart rate will be per-
formed after each contraction following randomization.
If electronic monitoring is considered necessary by the
birth attendant, the GAP procedure will not interfere
with monitoring as the monitor is positioned on the an-
terior aspect of the uterus while pressure is applied to
the fundal aspect.
Study outcomes
The primary outcome is defined as mean time (minutes)
from randomization to delivery.
Secondary outcomes include the following:
 Delivery outcomes:
o No spontaneous delivery within 15 min of
randomization;
o Operative delivery (vacuum, forceps or
caesarean section); and
o Episiotomy or 2nd/3rd degree tears.
 Neonatal outcomes:
o Cord blood pH < 7.2;
o 5-min Apgar score <7;
o Neonatal injury;
o Neonatal encephalopathy;
o Admission to neonatal high care nursery for
≥24 h; and
o Neonatal death.
Mothers will also be asked to grade their discomfort
experienced during the second stage of labour. All ad-
verse events and serious adverse events will also be
recorded.
Safety considerations
No drugs are being tested in this study. We are testing
interventions that are not taught or sanctioned by teach-
ing institutions in South Africa or elsewhere due to lack
of evidence, but practiced to varying degrees of fre-
quency. WHO does not currently recommend this pro-
cedure. The GAP method of applying fundal pressure
has been specifically developed to avoid the commonly
used, more vigorous form of fundal pressure. Therefore,
interventions which are practiced to some extent (fundal
pressure and posture) but for which there is little sup-
porting evidence are being tested by the study. We do
not anticipate any specific safety concerns over and
above those usually anticipated in the second stage of
labour.
However, some women may find specific birth posi-
tions and/or gentle fundal pressure uncomfortable. The
research staff will assist and support women to use the
allocated study position. Women may benefit from the
additional support. However, should a woman choose to
change birth position, or withdraw from the study for
any reason, it will not affect the medical care to which
she is entitled.
Adverse events
An adverse event is any untoward medical occurrence in
a patient or clinical investigation subject and which does
not necessarily have a causal relationship with this treat-
ment. An adverse event can therefore be any unfavour-
able and unintended sign (including an abnormal
laboratory finding), symptom, or disease temporally as-
sociated with the use of a medicinal (investigational)
product, whether or not related to the medicinal (inves-
tigational) product.
Any adverse event that requires treatment will be re-
ported an Adverse Event (AE) form and the principal in-
vestigator immediately alerted.
The serious adverse event form will be completed in
the following circumstances:
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 The woman has been transferred to another
department or hospital in relation to an adverse
event after enrolment in the trial.
 An adverse event has caused prolonged hospital
stay.
 The woman has been re-admitted to the hospital for
further care of an adverse event that has occurred
while she was in the trial.
 The adverse event has caused permanent loss of
function of a system or organ.
 The adverse event is considered to be life
threatening.
 The adverse event has resulted in death.
Reporting of AEs and SAEs will be done using an ad-
verse event (AE) form and serious adverse event (SAE)
form. These forms will be completed by data collectors
and the principal investigator informed as soon as pos-
sible. The WHO project manager will be notified of the
AE or SAE within 24 h, and the DSMC will be notified
of SAEs within 24 h (accelerated reporting).
Criteria for discontinuation
Criteria for discontinuation of a participant
Participants who no longer wish to remain in the study
will be discontinued.
Criteria for discontinuation of the study
An interim analysis by the statistical team is planned
after 50 % of women have completed the study. These
results will be reviewed by the Data Safety and Monitor-
ing Committee (DSMC). All adverse events and severe
adverse events will be provided to the DSMC on an ex-
pedited basis. If the Committee feels the data confirms
significant harm or benefit attributed to one of the study
arms and recommends discontinuation of the arm or
the study, enrolment will be stopped accordingly.
Follow-up procedures
Delivery details of screened, consenting women who are
not enrolled/randomized (e.g. who deliver before enrol-
ment by caesarean section or vaginal delivery) will be re-
corded on the relevant screening form.
Participating women and their neonates must be
followed up until discharge from the maternity and neo-
natal units. Therefore, we do not anticipate any loss to
follow-up. The case report forms are available upon
request.
For quality control, in a subset of cases a mobile
phone or camera-based video and sound recorder with
recorded time display may be set up behind the woman
prior to random allocation. The recorder will be posi-
tioned so that the mother’s identity is not seen. The re-
searcher’s recorded voice must document the time at
which the randomization envelope is opened, the pos-
ture of the woman, the use of fundal pressure, and the
time of delivery of the baby. The times will be tran-
scribed from the time sheet and/or the recording to the
paper CRF.
Recordings will only be used for research purposes; to
assess quality of recording of timing of events. These re-
cordings will be kept securely with other trial documen-
tation in the research office and be accessible only to
research staff. At the end of the study all recordings will
be destroyed.
Data management and quality assurance
Both the protocol and the trial report will include re-
quirements laid out in the CONSORT statemen[34 - see
reference on CONSORT]t. The protocol is registered
with the Pan African Clinical Trials Registry
(PACTR201502001034448). The first version of the stat-
istical analysis plan will be finalised before recruitment
begins. Participating research staff will be trained to cor-
rectly introduce the study to potential participants, ad-
minister the consent and correctly complete all study
forms as per the manual of operations and for entering
data in the web-based system. Each trial site will pilot
the trial procedures, including pilot testing the forms,
before recruitment. Refresher courses will be conducted
as considered necessary.
Randomization will take place when the woman's
name and hospital number is written in the
randomization register. Good Clinical Practice (GCP)
procedures will be followed. Data will be collected by re-
search staff onto paper CRFs.
Quality control will be performed on-site: a member
of each research team will be responsible for data entry
and query management, and ensuring that the CRFs are
correctly filled out. Completed CRFs will be randomly
checked by another member against the original patient
records for correctness. Any discrepancies will be imme-
diately addressed.
Data entry
The data will be entered in OpenClinica™, a web-based,
fully GCP-compliant data management system. The data
analyst at WHO Geneva will develop the data manage-
ment system, provide hosting, data back-ups and main-
tenance of the system.
A validation system will be built into the data manage-
ment system to ensure consistency, accuracy and com-
pleteness of the data collected (range checks, consistency
checks and skips). Double data entry will be performed
and queries will be resolved as much as possible before
discharge of the woman from hospital. First and second
data entry will be done as soon as the case report forms
are completed.
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It is unlikely that serious side-effects of the interven-
tion will occur. Adverse events and serious adverse
events, whether thought to be related to the trial inter-
vention or not, will be recorded by the researchers on
the adverse events CRFs which will be submitted to the
DSMC and the relevant ethics committees.
Data protection procedures
The following measures will be taken to ensure partici-
pant confidentiality:
 Trial data for each participant will be identified by a
unique ID number, not the participant’s name
 The trial register of names and trial ID numbers will
be kept separate from the CRFs
 Trial documents will be kept securely under lock
and key in the research offices and will not be
accessible, other than to the researchers
 Data will be entered by trial ID number in the
password-protected data management system to
which only trial staff will have access
 The trial report will not contain the names of any
participants
 After completion of the trial, the trial’s documents
will be kept secured for five years
Statistical methods
The sample size has been calculated to be powered to
detect a reduction in the primary outcome of mean time
(minutes) from randomization to delivery of > =3 min.
A reduction of > =3 min was used due to the findings of
the study by Api et al (2009) [31], that reported a time
from randomization to delivery of 23.1 min (SD 12.2
min) in the control group (N = 56), and 18.6 min (SD
9.5 min) in the fundal pressure group (N = 34). We as-
sumed that upright posture alone would likely lie be-
tween these two (i.e. approximately 20.0 min). Using the
Bonferroni rule to control for multiplicity, alpha is di-
vided by the number of comparisons (0.05/3 ≈ 0.02). We
assumed a power of 90 % and alpha of 95 %. The study
therefore requires 347 women in each arm, i.e. 1,041
women for all three arms. To allow for 10 % non-
compliance, we aim to recruit 382 in each arm. The final
sample size for the whole study is 1,145 women.
Data analysis
Data will be generated from the on-line data manage-
ment system and analysed in SPSS. The primary analysis
will be based on all subjects with outcome data available.
Any participants with protocol violations, including
women who no longer wish to receive their allocated
intervention but are prepared to have data collected, will
be analysed in the group to which they were allocated
(intention-to-treat). Data from subjects who withdraw
their consent will be excluded from the analysis and
considered as lost to follow-up.
Baseline characteristics will be compared between
groups to confirm the effectiveness of the randomization
process in creating similar groups. Numbers and base-
line characteristics of women lost to follow-up will also
be compared between study groups to detect any
imbalances.
Most study outcomes are categorical variables. For
these types of variables, the number of subjects, number
of missing values and percentages will be reported.
Categorical variables will be compared between study
arms as risk ratios with 95 % confidence intervals.
For continuous variables, e.g. time to delivery, the
number of subjects, and number of missing values, mini-
mum, maximum, means and standard deviations will be
reported. Appropriate transformation of non-normal or
skewed measurement will be performed. Means will be
compared using t-tests for two independent samples,
and 95 % confidence intervals will be calculated. If trans-
formations do not generate a distribution approaching
normality, medians and interquartile range (IQR) will be
reported. The primary outcome of the study is “mean
time (minutes) from randomization to delivery”. The
survival technique log-rank test will also be used to
compare the survival rates of the three groups, pairwise.
Results will be reported according to CONSORT guide-
lines [22].
Discussion
Expected outcomes of this study
The current widespread use of uncontrolled fundal pres-
sure is an important public health and human rights
issue, which this trial will seek to address. The study will
establish whether upright posture and/or a controlled
method of applying fundal pressure (GAP) can improve
labour outcomes for women and/or their babies. If fun-
dal pressure is found to have a measurable beneficial ef-
fect in this study, this gentle approach can be promoted
as a replacement for the uncontrolled methods currently
in use. If it is not found to be useful in this study, fundal
pressure can be discouraged.
Dissemination
The investigators are committed to the widespread dis-
semination of the findings of this study. We will seek to
publish the results in a peer-reviewed journal, in addition
to making the results available to the country Department
of Health, to inform labour care policy and training. Study
data will also be incorporated into our review of fundal
pressure in the Cochrane Library, which is recognised as a
leading source of evidence-based information. The review
will appear in the WHO Reproductive Health Library,
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which is freely available on the internet in developing
countries, and in several languages.
Anticipated problems and solutions
The main potential problem that we anticipate may be a
slow rate of recruitment. To minimize this possibility,
dedicated research staff will be appointed at the recruit-
ing sites. In addition, recruitment will be closely moni-
tored and, if inadequate, consideration will be given to
including additional sites or extending the duration of
the study. The trial procedures are straightforward and
have been shown in a pilot study to be feasible. As pos-
ture during labour is a potential confounding factor for
studies of fundal pressure, we have eliminated the poten-
tial for this variable to confound results by designing a
three-arm trial.
Project management
This project will be managed by the UNDP/UNFPA/
UNICEF/WHO/World Bank Special Programme of
Research, Development and Research Training in Human
Reproduction (HRP), Department of Reproductive Health
and Research, World Health Organization, Geneva,
Switzerland. In South Africa, the country principal investi-
gators will establish the research teams that will imple-
ment the research activities. The study coordinating unit
in Geneva will conduct site visits before and during the
implementation of the study to contribute to study site se-
lection, training workshops and assessment of adherence
to study protocols. There will be continuous communica-
tion between country research teams and study coordinat-
ing unit at the WHO. Regular contact will be made to
ensure that the timeline are followed and problems solved
without delay.
A Data Safety Monitoring Committee (DSMC) will be
established to safeguard the interests of the trial's partic-
ipants, potential participants, investigators and sponsors,
to assess the safety and efficacy of the trial's intervention
according to adverse event data available while the trial
is ongoing, and all other data available at a predefined
schedule, to monitor the trial's overall conduct and qual-
ity, and protect its validity and credibility and to make
recommendations concerning continuation or termin-
ation of study or any other modification necessary based
on the observed effects of the intervention.
Ethical considerations
The main ethical consideration relates to the timing
of recruitment. The WHO RHR and the Effective
Care Research Unit have extensive experience in re-
cruitment of women for interventions around the
time of childbirth. These trials have shown that it is
feasible to recruit women in early labour, and that it
is acceptable to women.
All women will receive information about the trial in
their language of choice, conforming to ethical require-
ments for research involving human subjects. The lan-
guage is non-technical and easily understood. Participants
will be given time to reflect on the information. After sign-
ing the informed consent form, participants will be free to
withdraw from the trial at any stage without loss of bene-
fits. If a woman is illiterate, an impartial witness will be
present during the entire informed consent reading and
discussion. The impartial witness will also sign and date
the ICF, along with the individual who performed the in-
formed consent discussion. The telephone numbers of in-
vestigators will be made available participants in the event
that they require further information or assistance.
There will be no payment for participation. Only com-
pensation for time spent completing trial procedures as
approved or requested by local ethics committees to be
appropriate and non-coercive will be considered.
The study protocol (WHO Study A65866) was reviewed
and approved by the WHO Research Project Review Panel
(RP2) and the WHO Ethics Review Committee. Ethics
The University of the Witwatersrand Committee for
Research on Human Subjects (HREC) has approved this
study protocol (Ethics clearance certificate no. M131054).
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